Purchase Order 36C24924P1153

Award Date 8/22/24
Potential Completion Date 9/3/24
Potential Value $14K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order to Mckesson Corporation, doing business as Mckesson, for the emergency procurement of the pharmaceutical drug chlorambucil. The $13,884 contract has an ultimate completion date of October 31, 2024 and is not associated with any set-aside designation. Mckesson is a healthcare services and information technology company that has provided a range of pharmaceutical products and services to multiple federal agencies,...
The U.S. Department of Veterans Affairs awarded a firm-fixed price purchase order contract worth $13,884.00 to Mckesson Corporation, a healthcare services and IT company, for the supply of 282,343 units of the drug chlorambucil 2 mg. The contract has an ultimate completion date of September 29, 2024. This award was not set aside for any specific business category. Mckesson has a history of providing pharmaceuticals, medical supplies, and healthcare IT solutions to various federal agencies,...
This firm fixed-price purchase order was awarded to Mckesson Corporation, a healthcare services and information technology company, by the Department of Veterans Affairs' Veterans Integrated Service Network 9 for the delivery of the pharmaceutical drug LEUKERAN (chlorambucil) 2mg. The contract has a ceiling value of $13,884.00 and an ultimate completion date of August 3, 2024. No set-aside designation was used. Mckesson has previously provided a variety of pharmaceutical products and services to...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and IT company, to provide CHLORAMBUCIL (LEUKERAN) 2MG FOR ST medication. The contract has a completion date of February 23, 2025 and a ceiling value of $28,928.50. Mckesson is the prime contractor and no set-aside designation was used. Mckesson has previously provided various pharmaceutical products and services to...
This firm fixed price federal contract with award number 36C24925P0225 was issued by the Department of Veterans Affairs (VA) to Mckesson Corporation, a healthcare services and information technology company. The contract is for the delivery of CHLORAMBUCIL (LEUKERAN) 2MG pharmaceutical products, with a ceiling value of $14,439.25 and a completion date of December 26, 2024. Mckesson has a history of providing a range of pharmaceutical products and services to various federal agencies, including...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to the prime contractor, Mckesson Corporation, for the supply of 25-tablet bottles of the drug Leukeran (chlorambucil) with a ceiling value of $13,884.00. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 2, 2024. No set-aside designation was used. Mckesson Corporation is a healthcare services and information technology...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and information technology company. The $28,878.50 contract is for the delivery of LEUKERAN (CHLORAMBUCIL) 2MG TAB BOTTLE (2 BOTTLES) to support VA medical centers. No set-aside was used for this award. The award indicates that Mckesson has provided a range of pharmaceutical products and services to federal agencies such...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to McKesson Corporation, a healthcare services and information technology company, for the provision of the chemotherapy drug melphalan (50mg+ 10mg injections) for use in oncology. The contract has a ceiling value of $89,828.16 and a completion date of September 30, 2017. No set-aside designation was used. McKesson has previously provided a range of pharmaceutical products and services to other federal...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the Department of Veterans Affairs, to Mckesson Corporation, a prominent healthcare services and IT company. The contract, valued at $28,878.50, is for the delivery of 3 bottles of the pharmaceutical drug Leukeran (chlorambucil) 2mg tablets. The award does not have a set-aside designation. Mckesson Corporation is the prime contractor, and the contract performance...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to the prime contractor Mckesson Corporation, doing business as Mckesson, for the provision of LEUKERAN (CHLORAMBUCIL) TAB 2MG 25 TABS/BOTTLE. The contract has an ultimate completion date of March 31, 2025 and a ceiling value of $14,439.25. No set-aside designation was used. Mckesson is a healthcare services and information technology company that provides...

This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Mckesson Corporation, a healthcare services and information technology company, for the emergency procurement of chlorambucil, a pharmaceutical used in the treatment of certain cancers. The contract has a ceiling value of $13,884.00 and an ultimate completion date of September 3, 2024. No set-aside designation was used for this award. Mckesson, the prime contractor, is a major supplier of pharmaceuticals, medical supplies, and healthcare IT solutions to various federal agencies, including the Department of Justice's Bureau of Prisons, the Department of Health and Human Services' Indian Health Service, and the Peace Corps, through indefinite delivery/indefinite quantity contract vehicles and blanket purchase agreements. This award appears to be part of Mckesson's broader federal healthcare contracting portfolio, which includes over $5.8 million in pharmaceutical deliveries to the Indian Health Service and the VA's Veterans Health Administration.

Generated 8/24/24, 9:04 AM